USPTO serial 78131369
CXR BIOSCIENCES
Reviewed by CopyMark Law Group
Reg. 2791110Status 710
- Filing date
- Status date
- Registration date
- Dec 9, 2003
- Examiner
- FAIRBANKS, RONALD L
- Law office
- TMO LAW OFFICE 112
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with CXR BIOSCIENCES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Martha Gayle Barber
Martha Gayle Barber Alston & Bird LLP101 South Tryon Street, Suite 4000Charlotte, NC 28280-4000UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | CHEMICAL OR BIOCHEMICAL PRODUCTS FOR RESEARCH PURPOSES, NAMELY, [ANTIBODIES, INTERFERONS,] [PRECURSORS FOR IN VITRO GENETIC ENGINEERING USE AND POLYPEPTIDES; CHEMICALS OR BIOCHEMICALS FOR BIOTECHNOLOGICAL RESEARCH, NAMELY,] [ANTIBODIES, INTERFERONS,] [PRECURSORS FOR IN VITRO GENETIC ENGINEERING USE AND POLYPEPTIDES; CHEMICALS OR BIOCHEMICALS FOR USE IN SCIENTIFIC RESEARCH, NAMELY,] [ANTIBODIES, INTERFERONS,] [PRECURSORS FOR IN VITRO GENETIC ENGINEERING USE AND POLYPEPTIDES;] [ DIAGNOSTIC PREPARATIONS, OTHER THAN FOR MEDICAL OR VETERINARY USE, NAMELY, ][ANTIBODIES, INTERFERONS,] [PRECURSORS FOR IN VITRO GENETIC ENGINEERING USE AND POLYPEPTIDES;] [REAGENTS FOR IN VITRO OR IN VIVO USE, OTHER THAN FOR MEDICAL USE; CHEMICAL OR BIOCHEMICALS FOR USE IN THE MANUFACTURE OF DRUGS, NAMELY,] [ANTIBODIES, INTERFERONS,] [PRECURSORS FOR IN VITRO GENETIC ENGINEERING USE AND POLYPEPTIDES;] BIOLOGICAL PREPARATIONS FOR LABORATORY PURPOSES OR FOR SCIENTIFIC PURPOSES, NAMELY, [ANTIBODIES, INTERFERONS,] PRECURSORS FOR IN VITRO GENETIC ENGINEERING USE AND POLYPEPTIDES; AND SUBSTANCES PRODUCED BY CHEMICAL ENGINEERING, BUT NOT FOR MEDICAL USE, NAMELY,[ ANTIBODIES, INTERFERONS,] PRECURSORS FOR IN VITRO GENETIC ENGINEERING USE AND POLYPEPTIDES | SECTION 8 - CANCELLED | — |
| 005 | [BIOCHEMICAL PREPARATIONS FOR MEDICAL USE IN THE NATURE OF [ANTIBODIES, INTERFERONS,] PRECURSORS FOR IN VITRO GENETIC ENGINEERING USE AND POLYPEPTIDES; BIOTECHNOLOGICAL PREPARATIONS FOR VETERINARY USE IN THE NATURE OF [ANTIBODIES, INTERFERONS,] PRECURSORS FOR IN VITRO GENETIC ENGINEERING USE AND POLYPEPTIDES; CHEMICAL OR BIOCHEMICAL OR BIOCHEMICAL PRODUCTS FOR MEDICAL OR VETERINARY PURPOSES OR RESEARCH IN THE NATURE OF [ANTIBODIES, INTERFERONS,] PRECURSORS FOR IN VITRO GENETIC ENGINEERING USE AND POLYPEPTIDES; [CLINICAL DIAGNOSTIC REAGENTS;] MEDICAL AND VETERINARY REAGENTS FOR MEDICAL LABORATORY USE; BIOACTIVE SUBSTANCES OBTAINED FROM ANIMALS OR BY SYNTHESIS, NAMELY[ ANTIBODIES, INTERFERONS,] PRECURSORS FOR IN VITRO GENETIC ENGINEERING USE AND POLYPEPTIDES; AND BIOLOGICAL SUBSTANCES FOR MEDICAL USE, namely, [ANTIBODIES, INTERFERONS,] PRECURSORS FOR IN VITRO GENETIC ENGINEERING USE AND POLYPEPTIDES] | SECTION 8 - CANCELLED | — |
| 009 | [APPARATUS FOR CARRYING OUT ASSAYS, NAMELY, CHROMATOGRAPHY APPARATUS, ELECTROPHORESIS APPARATUS, SPECTROSCOPY APPARATUS, MICROARRAYS AND TISSUE CULTURE APPARATUS; APPARATUS FOR SCIENTIFIC USE, NAMELY, CHROMATOGRAPHY APPARATUS, ELECTROPHORESIS APPARATUS, SPECTROSCOPY APPARATUS, MICROARRAYS, TISSUE CULTURE APPARATUS AND BIOREACTORS; APPARATUS FOR RESEARCH PURPOSES, namely, CHROMATOGRAPHY APPARATUS, ELECTROPHORESIS APPARATUS, SPECTROSCOPY APPARATUS, MICROARRAYS AND TISSUE CULTURE APPARATUS, DIAGNOSTIC APPARATUS FOR SCIENTIFIC USE, NAMELY, CHROMATOGRAPHY APPARATUS; DIAGNOSTIC APPARATUS FOR SCIENTIFIC USE, NAMELY, CHROMATOGRAPHY APPARATUS; ELECTROPHORESIS APPARATUS, SPECTROSCOPY APPARATUS, MICROARRAYS AND TISSUE CULTURE APPARATUS; AND ELECTROPHORESIS APPARATUS, SPECTROSCOPY APPARATUS, MICROARRAYS AND TISSUE CULTURE APPARATUS] | SECTION 8 - CANCELLED | — |
| 042 | Biotechnological research; scientific research; services for assessing the safety or efficiency of medical, veterinary or scientific research drugs; medical research; consultancy services relating to the development of dental, medical and scientific products; advisory services relating to the design of safety programs; advisory and consultancy services relating to scientific, medical and veterinary regulatory procedures and requirements | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CXR Biosciences Limited
- Other trademarks owned by CXR Biosciences Limited
- Other trademarks owned by CXR Biosciences Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named CXR BIOSCIENCES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 21, 2024 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Dec 9, 2022 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Dec 2, 2013 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Dec 2, 2013 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Dec 2, 2013 | 9G8P | REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8 | — |
| Dec 2, 2013 | 8PRT | REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED | — |
| Nov 18, 2013 | 89AF | REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED | — |
| Nov 18, 2013 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Jan 8, 2010 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jan 5, 2010 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 28, 2009 | 815F | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | — |
| Dec 28, 2009 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Nov 10, 2008 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 10, 2008 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 9, 2003 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 16, 2003 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 27, 2003 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 23, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 21, 2003 | CFIT | CASE FILE IN TICRS | — |
| Jul 2, 2003 | 1.BD | Sec. 1(B) CLAIM DELETED | — |
| Jul 2, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 2, 2003 | PAPER RECEIVED | — | |
| May 1, 2003 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 21, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 21, 2003 | PAPER RECEIVED | — | |
| Sep 21, 2002 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 20, 2002 | DOCK | ASSIGNED TO EXAMINER | — |